Exploring Interactions Between Growth Hormone and the Microbiome
NCT ID: NCT03327207
Last Updated: 2020-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2017-11-01
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Growth Hormone (GH) Treatment on Eating Regulation
NCT00562705
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
NCT00097513
Metabolic and QOL Effects of GH Treatment in Patients With TBI and AGHD
NCT02988687
Growth Hormone Secretion Following the Anaerobic Exercise
NCT01934270
Detection of Difficulties and Improvement Compliance to Growth Hormone Treatment
NCT03005561
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study group
Children who receive Growth hormone treatment. Non Interventional
Non Interventional
Non Interventional
Control group
Healthy children . Non Interventional
Non Interventional
Non Interventional
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non Interventional
Non Interventional
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* End state renal disease (ESRD)
* Prader-Willi syndrome
* Systemic illness
* Antibiotics/Antifungal in the last 3m
3 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weizmann Institute of Science
OTHER
Rambam Health Care Campus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pediatric endocrinology unit rambam medical center
Haifa, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Smadar Shilo, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0132-17 RMB CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.